Zobrazeno 1 - 10
of 1 897
pro vyhledávání: '"A, Yndestad"'
Autor:
Grace C. Wright, Eduardo Mysler, Kenneth Kwok, Mary Jane Cadatal, Rebecca Germino, Arne Yndestad, Cassandra D. Kinch, Alexis Ogdie
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 5, Pp 1135-1164 (2024)
Abstract Introduction Racial disparities in disease activity, clinical outcomes, and treatment survival persist despite advancements in rheumatoid arthritis (RA) therapies and clinical management. In this post hoc analysis of pooled data from the tof
Externí odkaz:
https://doaj.org/article/7fc4cc04798247339219428e07071d32
Autor:
Lars Erik Kristensen, Atul Deodhar, Ying-Ying Leung, Ivana Vranic, Mahta Mortezavi, Lara Fallon, Arne Yndestad, Cassandra D. Kinch, Dafna D. Gladman
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 3, Pp 487-499 (2024)
Abstract In this commentary, we review clinical data which helps inform individualized benefit–risk assessment for tofacitinib in patients with psoriatic arthritis (PsA) and ankylosing spondylitis (AS). ORAL Surveillance, a safety trial of patients
Externí odkaz:
https://doaj.org/article/0dfdf61802f742879087a07fe9f0706d
Autor:
Synnøve Yndestad, Hans Kristian Haugland, Dorota Goplen, Dorota Wojcik, Stian Knappskog, Per Eystein Lønning
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: While soft tissue sarcomas affect younger patients, few studies have assessed the distribution of underlying pathogenic germline variants. Patients and methods: We retrospectively identified all pediatric and young adult patients (0–22
Externí odkaz:
https://doaj.org/article/cae93a76423c4eee98bc61f97a74681b
Autor:
Olsen, Maria Belland, Louwe, Mieke C., Yang, Kuan, Øgaard, Jonas, Dahl, Tuva Børresdatter, Gregersen, Ida, Alfsnes, Katrine, Lauritzen, Knut H., Murphy, Sarah Louise, Ahmed, Muhammad Shakil, Aukrust, Pål, Vinge, Leif Erik, Yndestad, Arne, Holven, Kirsten B., Halvorsen, Bente, Fosshaug, Linn Elisabeth
Publikováno v:
In Biochemical and Biophysical Research Communications 12 November 2024 733
Autor:
Oleksii Nikolaienko, Hans P. Eikesdal, Elisabet Ognedal, Bjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, Emiel A. M. Janssen, Synnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, Stian Knappskog, Per E. Lønning
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Normal cell BRCA1 epimutations have been associated with increased risk of triple-negative breast cancer (TNBC). However, the fraction of TNBCs that may have BRCA1 epimutations as their underlying cause is unknown. Neither are the
Externí odkaz:
https://doaj.org/article/0089602380aa46b390f13cb9bbdb281f
Autor:
Arne Yndestad, Maya H Buch, Carol A Connell, Kenneth Kwok, Ted Mikuls, Deepak L Bhatt, Jon T Giles, Christina Charles-Schoeman, Gary G Koch, Edward Nagy, Steven Ytterberg, Hyejin Jo, Karim Richard Masri
Publikováno v:
RMD Open, Vol 10, Iss 2 (2024)
Objectives Compare the risk of extended major adverse cardiovascular (CV) event (MACE) composite outcomes and component events in patients with rheumatoid arthritis (RA) treated with tofacitinib versus tumour necrosis factor inhibitors (TNFi) in Oral
Externí odkaz:
https://doaj.org/article/ecd72b34dd1d469b9cb491e81996c9d4
Autor:
Hedda Hoel, Tuva Børresdatter Dahl, Kuan Yang, Linda Gail Skeie, Annika Elisabet Michelsen, Thor Ueland, Jan Kristian Damås, Anne Ma Dyrhol-Riise, Børre Fevang, Arne Yndestad, Pål Aukrust, Marius Trøseid, Øystein Sandanger
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 13, p 7141 (2024)
Antiretroviral treatment (ART) has converted HIV from a lethal disease to a chronic condition, yet co-morbidities persist. Incomplete immune recovery and chronic immune activation, especially in the gut mucosa, contribute to these complications. Infl
Externí odkaz:
https://doaj.org/article/2082d071afd1473c96cbdea9fab7a235
Autor:
Lars Erik Kristensen, Victoria Navarro-Compán, Marina Magrey, Andrew G. Bushmakin, Joseph C. Cappelleri, Arne Yndestad, Oluwaseyi Dina, Peter C. Taylor
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 4, Pp 1073-1087 (2023)
Abstract Introduction Tofacitinib is an oral Janus kinase inhibitor for treatment of ankylosing spondylitis (AS). Using mediation modelling, we describe interrelationships between fatigue, pain, morning stiffness, C-reactive protein (CRP) and tofacit
Externí odkaz:
https://doaj.org/article/3c522789b45749f6a6d68b464bcbeb6a